Bo Lagerqvist Selected Research

Dalteparin (Dalteparin Sodium)

2/2012	Timing of angiography with a routine invasive strategy and long-term outcomes in non-ST-segment elevation acute coronary syndrome: a collaborative analysis of individual patient data from the FRISC II (Fragmin and Fast Revascularization During Instability in Coronary Artery Disease), ICTUS (Invasive Versus Conservative Treatment in Unstable Coronary Syndromes), and RITA-3 (Intervention Versus Conservative Treatment Strategy in Patients With Unstable Angina or Non-ST Elevation Myocardial Infarction) Trials.
1/2012	Usefulness of the admission electrocardiogram to predict long-term outcomes after non-ST-elevation acute coronary syndrome (from the FRISC II, ICTUS, and RITA-3 [FIR] Trials).
6/2010	Long-term outcome of a routine versus selective invasive strategy in patients with non-ST-segment elevation acute coronary syndrome a meta-analysis of individual patient data.
2/2010	Growth-differentiation factor-15 for long-term risk prediction in patients stabilized after an episode of non-ST-segment-elevation acute coronary syndrome.
7/2009	Prognostic value of biomarkers during and after non-ST-segment elevation acute coronary syndrome.
9/2008	Pathophysiologic mechanisms of persistent cardiac troponin I elevation in stabilized patients after an episode of acute coronary syndrome.
10/2007	Persistent cardiac troponin I elevation in stabilized patients after an episode of acute coronary syndrome predicts long-term mortality.
11/2006	Oxidized low-density lipoprotein as a predictor of outcome in patients with unstable coronary artery disease.
3/2006	Improved identification of patients with coronary artery disease by the use of new lipid and lipoprotein biomarkers.
12/2005	Genetic variations in the tissue factor gene are associated with clinical outcome in acute coronary syndrome and expression levels in human monocytes.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Bo Lagerqvist Research Topics

Disease

45	Thrombosis (Thrombus) 01/2021 - 03/2004
38	Myocardial Infarction 11/2021 - 05/2002
26	ST Elevation Myocardial Infarction 01/2019 - 12/2003
21	Acute Coronary Syndrome 09/2017 - 12/2005
18	Coronary Artery Disease (Coronary Atherosclerosis) 02/2022 - 05/2002
13	Hemorrhage 01/2020 - 04/2011
12	Stroke (Strokes) 11/2021 - 11/2010
10	Heart Diseases (Heart Disease) 11/2021 - 10/2010
9	Heart Failure 11/2021 - 03/2011
7	Unstable Angina 01/2017 - 12/2003
7	Diabetes Mellitus 06/2015 - 09/2006
5	Infarction (Infarctions) 03/2019 - 03/2007
5	Non-ST Elevated Myocardial Infarction 01/2017 - 02/2012
4	Breast Neoplasms (Breast Cancer) 01/2020 - 02/2012
4	Coronary Disease (Coronary Heart Disease) 01/2019 - 05/2002
3	Pathologic Constriction (Stenosis) 01/2014 - 02/2012
2	Coronary Stenosis (Coronary Artery Stenosis) 03/2019 - 02/2012
2	Peripheral Vascular Diseases (Peripheral Vascular Disease) 01/2019 - 01/2016
2	Stable Angina 01/2017 - 03/2004
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2016 - 06/2003
2	Inflammation (Inflammations) 02/2010 - 12/2003
1	Renal Insufficiency (Renal Failure) 11/2021
1	MINOCA 01/2019
1	Heart Arrest (Cardiac Arrest) 01/2019
1	Cardiogenic Shock 01/2018
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 09/2017
1	Chronic Renal Insufficiency 01/2017
1	Kidney Diseases (Kidney Disease) 01/2017
1	Ischemic Stroke 01/2016
1	Coronary Occlusion 01/2014
1	Overweight 02/2013
1	Hypertension (High Blood Pressure) 03/2011
1	Myocardial Ischemia (Ischemic Heart Diseases) 02/2010

Drug/Important Bio-Agent (IBA)

13	Dalteparin (Dalteparin Sodium)FDA Link 02/2012 - 06/2003
8	Clopidogrel (Plavix)FDA Link 10/2018 - 04/2011
6	TicagrelorIBA 01/2019 - 01/2016
6	MetalsIBA 09/2018 - 03/2007
5	Glucose (Dextrose)FDA LinkGeneric 11/2021 - 06/2015
4	Biomarkers (Surrogate Marker)IBA 01/2019 - 03/2006
4	Pharmaceutical PreparationsIBA 09/2018 - 01/2010
4	bivalirudin (Angiomax)FDA Link 03/2017 - 09/2011
4	Glycoproteins (Glycoprotein)IBA 01/2017 - 08/2010
4	Heparin (Liquaemin)FDA LinkGeneric 01/2017 - 11/2010
4	LipidsIBA 01/2014 - 03/2004
4	Troponin IIBA 07/2009 - 06/2003
3	CreatinineIBA 01/2019 - 12/2006
3	oxidized low density lipoproteinIBA 01/2014 - 03/2006
3	TroponinIBA 10/2007 - 09/2006
2	Warfarin (Coumadin)FDA LinkGeneric 01/2020 - 10/2009
2	cangrelorIBA 01/2019 - 01/2017
2	Everolimus FDA Link 08/2018 - 11/2012
2	Prasugrel Hydrochloride FDA Link 01/2017 - 01/2014
2	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 01/2017 - 04/2014
2	Insulin (Novolin)FDA Link 06/2015 - 10/2009
2	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 04/2014 - 04/2011
2	LDL CholesterolIBA 01/2014 - 03/2006
2	AnticoagulantsIBA 09/2011 - 04/2011
2	Growth Differentiation Factor 15IBA 02/2010 - 10/2007
2	C-Reactive ProteinIBA 07/2009 - 09/2006
2	Brain Natriuretic Peptide (Natrecor)FDA Link 07/2009 - 12/2003
2	pro-brain natriuretic peptide (1-76)IBA 07/2009 - 12/2003
2	Interleukin-6 (Interleukin 6)IBA 09/2006 - 12/2003
2	LDL Lipoproteins (beta Lipoproteins)IBA 03/2006 - 03/2004
2	HDL LipoproteinsIBA 03/2006 - 03/2004
1	regadenoson FDA Link 02/2022
1	Adenosine (Adenocard)FDA LinkGeneric 02/2022
1	IncretinsIBA 01/2021
1	Metformin (Glucophage)FDA LinkGeneric 11/2020
1	Tamoxifen FDA LinkGeneric 01/2020
1	Estrogen ReceptorsIBA 01/2020
1	PolymersIBA 08/2018
1	Oxygen (Dioxygen)IBA 01/2018
1	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 01/2016
1	Phenobarbital (Luminal)FDA Link 01/2014
1	ElementsIBA 07/2013
1	Biological ProductsIBA 01/2013
1	Sirolimus (Rapamycin)FDA Link 11/2012
1	Paclitaxel (Taxol)FDA LinkGeneric 11/2012
1	antineoplaston A10 (A 10)IBA 03/2011
1	Eptifibatide (Integrilin)FDA Link 08/2010
1	Abciximab (ReoPro)FDA Link 08/2010
1	CholesterolIBA 03/2006
1	1-Alkyl-2-acetylglycerophosphocholine Esterase (PAF Acetylhydrolase)IBA 03/2006
1	HDL CholesterolIBA 03/2006
1	Lipoproteins (Lipoprotein)IBA 03/2006

Therapy/Procedure

45	Stents 01/2021 - 03/2007
37	Percutaneous Coronary Intervention 01/2021 - 01/2010
19	Therapeutics 11/2021 - 07/2005
11	Drug-Eluting Stents 01/2021 - 03/2007
7	Patient Readmission 01/2018 - 07/2008
6	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 01/2018 - 03/2004
5	Conservative Treatment 02/2012 - 07/2008
3	Thrombectomy 01/2018 - 04/2016
2	Radiotherapy 08/2016 - 02/2012
1	Conformal Radiotherapy 03/2019
1	Aftercare (After-Treatment) 01/2016
1	Catheters 06/2015
1	Duration of Therapy 04/2014
1	Drug Therapy (Chemotherapy) 03/2011
1	Off-Label Use 04/2009